Rosiglitazone
Links shared publicly online about this topic
Fate of rosiglitazone
theheart.org — “After the release of the Senate report last weekend, experts had varying opinions on the future of the drug. Some, including FDA officials, called for it to be pulled from the market, while others felt rosiglitazone still had a role in select patients. Overall, though, most felt the evidence favors pioglitazone when choosing one of the TZDs.” View full resource at theheart.org
Most Recently Shared on February 24, 2010 at 7:40 pm By:
Experts debate future of rosiglitazone in the wake of critical Senate report: After the release of the Senate repo... http://bit.ly/bfMg6t
Rosiglitazone on #MDlinx
mdlinx.com — “Rosiglitazone on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 7, 2010 at 6:46 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
The Effect of Rosiglitazone on Retinol Binding Protein 4 in Subjects of Impaired Glucose Tolerance: The Endoc... http://bit.ly/c17wS5 #endo
Rosiglitazone storm poised for touchdown
theheart.org — “UPDATED // The FDA documents, which provide a glimpse of what the agency's presentations will look like next week, are largely critical of rosiglitazone's safety record and of the ethics of the ongoing TIDE trial. In sharp contrast, GlaxoSmithKline's documents reiterate the need for a randomized controlled trial to resolve uncertainties and conclude that by and large the data support” View full resource at theheart.org
Most Recently Shared on July 9, 2010 at 1:17 pm By:
Rosiglitazone review just days away; FDA posts briefing documents online: Journalists invited to a unique preheari... http://bit.ly/bf1A7f
Risks of the Drug Avandia (Rosiglitazone)
healthline.com — “Risks of the Drug Avandia (Rosiglitazone)” View full resource at healthline.com
Most Recently Shared on May 23, 2007 at 7:28 am By:
Joshua Schwimmer Doctor, Internist, Nephrologist, and Physician
New Tech Medicine post on Avandia: http://tinyurl.com/28m9oy
Rosiglitazone safety questioned, again
theheart.org — “The drug was associated with more deaths and more heart failure than pioglitazone in an analysis of outpatients from across Ontario; no difference was seen in the risk of MI.” View full resource at theheart.org
Most Recently Shared on August 19, 2009 at 8:16 pm By:
heartwire: Rosiglitazone safety questioned, again, this time in population-based study http://bit.ly/3q9XKE
Halt Rosiglitazone (Avandia) Trial
citizen.org — “Halt Rosiglitazone (Avandia) Trial” View full resource at citizen.org
Most Recently Shared on May 14, 2010 at 9:44 pm By:
madan kwatra Doctor and PhD
Halt Rosiglitazone (Avandia) Trial: http://www.citizen.org/hrg1908 via @addthis
Ban Rosiglitazone (Avandia)
citizen.org — “Ban Rosiglitazone (Avandia)” View full resource at citizen.org
Most Recently Shared on April 21, 2010 at 1:10 pm By:
Sidney Wolfe, MD Doctor, Internist, and Physician
#FDA considers ending trial of #Avandia due to heart risks - just cut to the chase and ban it! http://bit.ly/aI4zT3 http://bit.ly/9bkQ8p
Halt Rosiglitazone (Avandia) Trial
citizen.org — “Halt Rosiglitazone (Avandia) Trial” View full resource at citizen.org
Most Recently Shared on July 14, 2010 at 2:23 pm By:
#Avandia - Dr Sidney Wolfe (Public Citizen) addresses OPH. PC's letter to FDA here: http://bit.ly/cBqWx3. Wolfe not a big Rosi fan.
Patients with diabetes have alternatives to rosiglitazone
theheart.org — “Following the recent controversial FDA advisory panel decision on rosiglitazone, the drug's future availability is uncertain. But how much does that matter to the treatment of most patients with type2 diabetes?” View full resource at theheart.org
Most Recently Shared on July 22, 2010 at 8:46 pm By:
Patients with diabetes have alternatives to rosiglitazone, experts say: Following the recent controversial FDA adv... http://bit.ly/bokb3A
Avandia (rosiglitazone) Use To Be Severely Restricted
medicalnewstoday.com — “The use of diabetes medication, Avandia (rosiglitazone) is to be significantly restricted to patients with diabetes Type 2 who are unable to control their diabetes on other drugs, the Food and Dru” View full resource at medicalnewstoday.com
Most Recently Shared on September 23, 2010 at 10:06 pm By:
Avandia (rosiglitazone) Use To Be Severely Restricted The use of diabetes medication, Avandia (rosiglitazone) is to be .. http://dld.bz/wMFQ
Senate report questions safety of rosiglitazone
endocrinetoday.com — “A new report released over the weekend by the United States Senate Committee on Finance brings more attention to the diabetes drug rosiglitazone” View full resource at endocrinetoday.com
Most Recently Shared on February 22, 2010 at 10:15 pm By:
Senate report questions safety of diabetes drug rosiglitazone http://ow.ly/1a5D2
Cardiology Medical News about rosiglitazone
mdlinx.com — “Randomized comparison of the effects of rosiglitazone vs. placebo on peak integrated cardiovascular performance, cardiac structure, and function” View full resource at mdlinx.com
Most Recently Shared on July 7, 2010 at 1:25 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Randomized comparison of the effects of rosiglitazone vs. placebo on peak integrated cardiovascular... http://bit.ly/c1Mkwe #cardio #mdlinx
Rosiglitazone maleate (marketed as Avandia, Avandamet, and Avandaryl) Information
fda.gov — “Rosiglitazone maleate (marketed as Avandia, Avandamet, and Avandaryl) Information” View full resource at fda.gov
Most Recently Shared on February 22, 2010 at 7:46 pm By:
eyeonfda Pharma and Health Lawyer
RT @mhuckman: New FDA communication (just posted) on Avandia. $GSK http://tinyurl.com/pmfdaava
Avandia (rosiglitazone): Ongoing Review of Cardiovascular Safety
fda.gov — “FDA is reviewing data from a large, long-term clinical study on possible risks for cardiovascular outcomes associated with use of rosiglitazone.” View full resource at fda.gov
Most Recently Shared on February 22, 2010 at 9:32 pm By:
eyeonfda Pharma and Health Lawyer
FDA issues MedWatch - Avandia (rosiglitazone): Ongoing Review of Cardiovascular Safety - http://ow.ly/1a4EB
Avandia (rosiglitazone) To Be Taken Off The Market In Europe
medicalnewstoday.com — “Avandia (rosiglitazone), and all diabetes medications that contain rosiglitazone will be taken off the market within the next few months, says the European Medicines Agency (EMA) which has recomme” View full resource at medicalnewstoday.com
Most Recently Shared on September 24, 2010 at 3:53 pm By:
Avandia (rosiglitazone) To Be Taken Off The Market In Europe http://bit.ly/cd1gV4
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
Advertisement
